Myomo to Present at the 30th Annual ROTH Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at the 30th Annual ROTH Conference in Dana Point, CA on Monday, March 12th at 9:00 AM PT, Blue – Salon 2. Chairman and Chief Executive Officer Paul R. Gudonis will be […]
Myomo to Present at Noble Capital Markets’ 14th Annual Investor Conference
Cambridge, MA., January 16, 2018 – Myomo, Inc. (NSYE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at NobleCon14 – Noble Capital Markets’ Fourteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 29th at 11:00 AM EST – Studio […]
Myomo, Inc. Announces Full Exercise of Underwriter’s Over-allotment Option in Follow-on Public Offering
CAMBRIDGE, Mass., December 6, 2017 – Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company, today announced that Roth Capital Partners, the underwriter of Myomo’s follow-on offering, exercised in full its option to purchase 626,250 shares of common stock and accompanying warrants to purchase 626,250 shares of common stock, at a combined price […]
Myomo Expands MyoPro® Centers of Excellence Program
Growing Nationwide Roster Supports MyoPro Powered Orthosis Cambridge, MA., November 29, 2017 – Myomo, Inc. (NSYE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the addition of six new orthotics and prosthetics (O&P) locations to its Center of Excellence (CoE) program, which recognizes top O&P practices that support the […]
Myomo, Inc. Files Registration Statement for Proposed Follow-On Offering
CAMBRIDGE, Mass., November 13, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, announced the filing of a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed underwritten follow-on public offering of shares of its common stock and accompanying warrants to purchase […]
Myomo, Inc. Issues November 2017 Shareholder Letter
CAMBRIDGE, Mass., November 7, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today issued a letter to shareholders to give an update on third quarter 2017 and ongoing MyoPro® commercial activities.
Myomo, Inc. Reports Third Quarter 2017 Results
CAMBRIDGE, Mass., November 6, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and nine months ended September 30, 2017. Read more.
Myomo Enters Canadian Market
Ottobock to Distribute MyoPro® to Orthotics and Prosthetics Practices Throughout Country CAMBRIDGE, Mass., November 03, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Application for a Canadian Medical Device License has been approved by Health Canada. With the license, Myomo and its […]
Myomo, Inc. Launches Awareness Program for Veterans of the U.S. Armed Forces
MyoPro® for Veterans is Designed to Broaden MyoPro Accessibility to the Many Veterans Who May Benefit. CAMBRIDGE, Mass., October 17, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical device company, today announced the launch of MyoPro For Veterans, a strategic awareness program that broadens accessibility of MyoPro powered […]
Myomo, Inc. Reports Second Quarter 2017 Results
CAMBRIDGE, Mass., August 14, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and six months ended June 30, 2017. Read more.